By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Windhover Information Inc. 

10 Hoyt Street

Norwalk  Connecticut  06851  U.S.A.
Phone: 203-838-4401 Fax: 203-838 3214



Company News
RetroSense Therapeutics Selected by Windhover Information Inc. as a "Top Project to Watch: Most Licensable Product" 10/29/2013 10:01:48 AM
Rib-X Pharmaceuticals, Inc.' RX-04 Program Will be Featured at Windhover Information Inc.'s Therapeutic Area Partnerships Meeting as a "Top 10 Infectious Diseases Project to Watch" 11/29/2012 9:51:54 AM
Addex Therapeutics (ADXN.SW)' Dipraglurant Named as one of the "Top 10 Neuroscience Projects to Watch" by Windhover Information Inc. and Virginia Herndon 11/27/2012 9:56:51 AM
Neogenix Oncology, Inc.'s Novel Antibody NEO-101 Named One of Windhover Information Inc.'s Top 10 Projects to Watch 11/30/2011 8:55:38 AM
Alvine Pharmaceuticals, Inc.'s ALV003 Named a Top 10 Inflammatory/Autoimmune Project to Watch by Windhover Information Inc. for a Rare Second Year 11/29/2011 10:07:27 AM
Naurex Inc.'s Novel Antidepressant GLYX-13 Recognized as One of Windhover Information Inc.'s 2011 Top 10 Neuroscience Projects to Watch 11/7/2011 12:29:19 PM
Tivorsan Pharmaceuticals, Inc.' Biglycan for Duchenne Muscular Dystrophy Named One of Windhover Information Inc.'s Top 10 “Hot Space” Projects to Watch 10/19/2011 10:34:38 AM
ImmunoCellular Therapeutics, Ltd' ICT-107 Recognized As One of Windhover’s Top 10 Most Licensable Oncology Products 9/28/2011 9:58:37 AM
Local Medical-Devices Firms Face Tougher Times, Says Director of Windhover Information Inc. 1/3/2011 8:05:42 AM
Stealth Peptides Inc.' Bendavia(TM) Recognized as One of Stealth Peptides Inc.'s Top 10 Cardiovascular and Metabolic Development Programs to Watch 11/8/2010 9:53:39 AM